Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Radkowski

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
HNO|February 9, 2016
[Not Available]P Riedel, R Radkowski, A Tannapfel, et al.
British Journal of Cancer|August 4, 2011
Inhibition of DNA repair with MGMT pseudosubstrates: phase I study of lomeguatrib in combination with dacarbazine in patients with advanced melanoma and other solid tumoursH A Tawbi, L Villaruz, A Tarhini, et al.
Leukemia|October 1, 2011
Long-term transfusion independence in del(5q) MDS patients who discontinue lenalidomideA A N Giagounidis, A Kulasekararaj, U Germing, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
HNO|February 9, 2016
[Not Available]P Riedel, R Radkowski, A Tannapfel, et al.
British Journal of Cancer|August 4, 2011
Inhibition of DNA repair with MGMT pseudosubstrates: phase I study of lomeguatrib in combination with dacarbazine in patients with advanced melanoma and other solid tumoursH A Tawbi, L Villaruz, A Tarhini, et al.
Leukemia|October 1, 2011
Long-term transfusion independence in del(5q) MDS patients who discontinue lenalidomideA A N Giagounidis, A Kulasekararaj, U Germing, et al.
Pageof 1